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Abstract: Several Vibrio spp. cause acute and severe mortality events in hatcheries where larvae of 
bivalve mollusks are reared, potentially leading to subsequent shortage of bivalve seed for the grow-
out industry. In particular, strains of Vibrio coralliilyticus have been identified as a major cause of 
disease in Pacific, Crassostrea gigas, and eastern, C. virginica, oyster hatcheries in the United States of 
America. Probiotic bacteria are an inexpensive, practical, and natural method of disease control. 
Previous research shows that pretreatment of larval oysters with probiotic bacteria Bacillus pumilus 
RI06–95 (RI) and Phaeobacter inhibens S4 (S4) significantly decreases mortality caused by 
experimental challenge with the bacterial pathogen V. coralliilyticus RE22 (RE22). This study aims to 
characterize the immune response of 6–10-day-old eastern oyster larvae to experimental challenge 
with pathogen V. coralliilyticus RE22 and probionts RI and S4. Treatments included (a) pathogen and 
probiont exposure at a concentration of 5 × 104 CFU per mL (~2500 bacterial cells per larva) for a 
duration of 6 h, (b) probiont exposure at the same concentration for a duration of 24 h, and (c) 
probiont RI daily treatment of larvae in the hatchery for 4, 11, and 15 days. Differential gene 
expression analysis compared pathogen or probiotic-treated transcriptomes to unexposed controls. 
Probiotic and pathogen treatment led to upregulation of transcripts coding for several immune 
pattern recognition receptors (PRRs) involved in environmental sensing and detection of microbes 
in oyster larvae. Larval oyster responses to pathogen RE22 suggested suppression of expression of 
genes in immune signaling pathways (myd88, tak1, nkap), failure in upregulation of immune effector 
genes, high metabolic demand, and oxidative stress that potentially contributed to mortality. On the 
other hand, the transcriptomic response to probiotic bacteria RI and S4 suggested activation of 
immune signaling pathways and expression of immune effectors (e.g., Cv-spi2, mucins and perforin-
2). These key features of the host immune response to probiotic bacteria were shared despite the 
length of probiotic exposure, probiotic species, and the type of environment in which exposures 
were conducted. This study suggests that pre-exposure of eastern oyster larvae to probiotics for 6–
24 h prior to pathogenic challenge leads to a robust and effective immune response that may 
contribute to protecting larvae from subsequent challenge with V. coralliilyticus RE22. This research 
provides new insights into host-microbe interactions in larval oysters that could be applied in the 
management of vibriosis in bivalve hatcheries. 
Keywords: Crassostrea virginica; Vibrio coralliilyticus; larvae; oyster hatchery; probiotics; Bacillus 
pumilus; Phaeobacter inhibens; transcriptome 
 
Vaccines 2020, 8, 588 2 of 23 
 
1. Introduction 
The Vibrionaceae constitutes a diverse bacterial family inhabiting a variety of ecological niches in 
aquatic environments. Several Vibrio spp. are well-known for their ability to cause disease in a broad 
range of marine, estuarine, and freshwater hosts, as well as in the terrestrial organisms that ingest 
vibrio-contaminated seafood or water [1–3]. These diseases, grouped under the generic name of 
vibriosis, have a significant economic and ecological impact, constraining the productivity of 
aquaculture and fisheries, affecting keystone species such as reef-building corals and bivalves, and 
placing a burden on public health, particularly in coastal regions [4–6]. 
Vibriosis is, in general, considered an opportunistic disease, affecting hosts at early life stages 
(e.g., larvae and juveniles) or when they are compromised (e.g., due to environmental stress or other 
diseases), therefore constituting an emerging problem due to stress caused by climate change [2,4,6]. 
In the case of bivalve mollusks (oysters, clams, scallops, mussels), vibriosis causes significant losses 
in hatcheries and nurseries that produce the larvae and seed supporting bivalve aquaculture, one of 
the most important sectors of aquaculture [7–11]. Several Vibrio spp. have been isolated from 
mortality outbreaks in bivalve hatcheries and nurseries, including V. aestuarianus, V. coralliilyticus, V. 
splendidus, V. tapetis, V. tasmaniensis, and V. tubiashii, to name a few. Strains of V. coralliilyticus, in 
particular, have been isolated from multiple outbreaks of disease in both Pacific oyster, Crassostreae 
gigas, and eastern oyster, C. virginica, hatcheries [7,12,13] and have been demonstrated to cause larval 
mortality in experimental infections [14–16]. Despite the diversity of Vibrio spp. able to cause disease 
in bivalve hatcheries, the clinical signs of vibriosis in larval bivalves are generally similar. Vibrio 
larval infection is dramatically rapid in progression and characterized with signs of reduced motility 
and feeding, bacillary necrosis, swarming of bacteria in the tissues and around the moribund larvae, 
and death within hours of infection [17]. Recent studies suggest that bivalve larvae and juveniles are 
unable to mount an effective immune response against vibrio challenge, as seen in mussel larvae in 
response to V. coralliilyticus [18] and in Pacific oysters in response to V. crassostreae and V. tasmaniensis 
[19,20]. 
Practices to reduce mortality due to bacterial disease in aquaculture systems include treatment 
with antibiotics and disinfection of seawater. Water treatment, however, is expensive and could be 
toxic to the larvae if not done properly, while antibiotic treatment raises environmental and human 
health concerns [21–23]. Therefore, alternative methods need to be developed to manage good larval 
rearing environment and to control bacterial diseases in bivalve shellfish hatcheries [24]. Probiotics 
are defined as live microbial food supplements that confer a health benefit on the host [25]. Probiotics 
are known to benefit the host by a variety of means, including production of antimicrobials, 
improving water quality, enhancing the immune responses of host, and competing for space with 
pathogenic bacteria [4,26–29]. The benefits of probiotics have already been shown in Pacific [30–32] 
and eastern [33,34] oysters. Pretreatment of larval and juvenile C. virginica with probiotic bacteria 
Phaeobacter inhibens S4 (referred to as S4) and Bacillus pumilus RI06–95 (RI) for at least one day 
improves eastern oyster survival after experimental challenge with the bacterial pathogens 
Aliiroseovarius crassostreae and Vibrio coralliilyticus RE22 (RE22) [33,34]. The mechanisms of action of 
these probiotics are likely complex. Similarly, to other Phaeobacter spp., probiont S4, a Gram-negative 
organism, is a strong biofilm former that produces the antibiotic tropodithietic acid (TDA) [35–38]. 
Although these two mechanisms are involved in protecting oysters and other organisms from 
bacterial infection, mutants of S4 unable to produce TDA and with decreased ability to produce 
biofilms still provide some level of protection [38], suggesting that other mechanisms are also 
potentially involved, including interference of quorum sensing signaling in the pathogen [39]. 
Probiont RI is a Gram-positive organism that produces the antibiotic amicoumacin, but this antibiotic 
does not inhibit the growth of RE22 in an in vitro assay, indicating that other mechanisms of action 
are also likely involved in RI’s protection of larvae against bacterial challenge [33]. There is growing 
evidence that probiotics show immunomodulatory effects in fish and shellfish [40,41]. Our 
hypothesis is that pre-treatment of oyster larvae with probionts RI and S4 may cause an activated 
immune state in eastern oyster larvae that contribute to protection against the pathogenic effects of 
RE22. 
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Based on the large economic impact of vibriosis on bivalve hatcheries worldwide [7–11], more 
research is needed to understand the variety of mechanisms used by vibrio species to evade 
immunity and cause disease in bivalve host species. More research is also needed on the development 
of effective tools, such as probiotics, to manage vibriosis in bivalve hatcheries. The goal of this study 
is to characterize the immune response of C. virginica larvae to experimental challenge with the 
bacterial pathogen V. coralliilyticus RE22 and two probiotic bacterial species, Phaeobacter inhibens S4 
and Bacillus pumilus RI06–95, using transcriptomic analysis. This research provides hypotheses on 
possible strategies used by RE22 to overcome larval immune defenses and increases our 
understanding on the role of immunomodulation as a potential mechanism of action of probiotics in 
providing protection against vibriosis. This knowledge will aid in the future development of 
solutions to control disease and design better management practices for bivalve hatcheries. 
2. Materials and Methods 
2.1. Bacterial Cultures 
The pathogen, Vibrio coralliilyticus RE22 [15] and probiotics, Bacillus pumilus RI06–95 and 
Phaeobacter inhibens S4 [33] were maintained and stored in 50% glycerol stocks at −80 °C until use. 
Inocula from freezer stocks were plated on yeast peptone with 3%NaCl (YP30; 5 g·L−1 of peptone, 1 
g·L−1 of yeast extract, 30 g·L−1 of ocean salt, Instant Ocean) agar plates for 1 d (for RE22) and 2 d (for 
RI06–95 and S4), then transferred to 5 mL of YP30 broth incubated at 25 °C on a shaker (134 rpm) for 
1 d (for RE22) and 2 d (for RI and S4). Cultures were washed using Artificial Filtered Sterile Seawater 
(AFSW, 28–30 psu salinity) twice by centrifugation at 12,000 rpm (13,100 rcf) for 10 min. The optical 
density at 550 nm (OD550) was measured and the stock was diluted such as to obtain target 
concentrations based on a previously determined relationship between colony forming units (CFU) 
and OD550 [33]. 
2.2. Oyster Larvae 
Eastern oyster, C. virginica, larvae were obtained from shellfish hatcheries on the east coast of 
United States of America. Larvae are most susceptible to V. coralliilyticus RE22 infection during the 
first two weeks of life [14,16]. Larvae 6–10 days old (veliger stage), selected from those passing 
through a 175 µm sieve but retained on a 100 µm sieve, were collected at the hatchery and shipped 
overnight to the laboratory on a wet filter in a box filled with ice blocks. Upon arrival, larvae were 
washed with AFSW (28–30 psu salinity, room temperature—RT, 22–23 °C) on top of a 40 µm nylon 
mesh and placed in stock containers containing AFSW. Larvae were acclimatized to the laboratory 
environment for 24 h prior to the experiments. Larval density (larvae mL−1) of the stock was 
determined using a Nikon E200 microscope (Nikon). 
2.3. Effect of V. coralliilyticus RE22 on Survival of C. virginica Larvae 
In order to understand the rate of progression of bacterial disease (vibriosis) and determine the 
optimal sampling time point for the transcriptome study, C. virginica larvae were experimentally 
challenged with V. coralliilyticus RE22 (Figure 1A). 
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Figure 1. Schematic showing experimental design for the larval survival and transcriptomic 
experiments performed. Labels (A–D) represent individual experimental designs. Treatments include 
probionts Phaeobacter inhibens S4 and Bacillus pumilus RI0-695, denoted as S4 and RI, respectively, 
pathogen V. coralliilyticus RE22, denoted as RE, and control denoted as C. 
Larvae (~100–175 µm in size) were distributed in wells of a 6-well plate (~100 per well) with 5 
mL AFSW and maintained at RT with gentle rocking. Treatments (control and RE22 challenge) were 
each conducted in triplicate. Larvae were challenged by addition of a target final concentration of  
5 × 105 CFU of RE22 per mL of water (~2.5 × 104 vibrio cells per larva) in each well mixed with 1 mL 
of instant algae Shellfish Diet 1800TM (20,000 cells mL−1; Reed Mariculture Inc., San Jose, CA. USA) in 
order to promote pathogen ingestion. Larval mortality was recorded at 6, 9, 14, 18, and 20 h post 
addition of RE22 by evaluation of active swimming and/or gut and cilia movement using a Nikon 
E200 microscope (Nikon) [33]. 
2.4. Effect of Length of Probiotic Pretreatment on Protection against Pathogen Challenge 
In order to determine the effect of pre-treatment of larvae with probiotics on protection against 
challenge with the bacterial pathogen V. coralliilyticus RE22, ~100 larvae (~100–175 µm) were placed 
in each well of a 6-well plate in 5 mL of AFSW and incubated with 5 × 104 CFU mL−1 of probionts S4 
or RI for either 6 h or 24 h (Figure 1B) prior to bacterial challenge with 5 × 105 CFU mL−1 of RE22. 
Treatments were each conducted in triplicate. Larval survival was determined 24 h after RE22 
challenge (time at which the survival of control challenged larvae ranged between 25 and 50%, while 
non-challenged larvae ranged between 80–100%) using previously described methods [33]. Survival 
rate was calculated as follows: Survival rate (%) = 100 × (number of live larvae/total number of larvae). 
One-way analysis of variance (ANOVA) on transformed data was used to determine significance 
between treatments and Tukey’s multiple comparison tests were used for post-hoc pairwise 
comparisons (p < 0.05) [34]. The relative percent survival (RPS) of probiotic pretreatment (treatment) 
compared to the challenged larvae (control) was calculated using the formula: 
RPS (%) = (1 − (% Mortality treatment / % Mortality control)) × 100 [33]. 
2.5. Effect of Bacterial Treatment on Larval Gene Expression: Laboratory Transcriptomes 
For biological replicates, three independent experiments were performed using larvae of the 
same size range (~100–175 µm) from three different hatcheries (designated as K, M, and V), to account 
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for variability in larval genetics and hatchery environments (Figure 1C). Two parallel exposures were 
performed with each set of larvae: 
a) Transcriptome analysis: 
Larvae were distributed into sterile tissue culture flasks (~10,000 per flask) in 500 mL AFSW and 
kept on a shaker with gentle shaking at ~50 rpm at room temperature. Larvae were acclimatized to 
the experimental set up for an additional 24 h prior to treatment. Each treatment (control, probiont 
RI and S4, and pathogen RE22) was conducted in duplicate to serve as technical replicates. Bacterial 
treatments were performed by adding them at a concentration of 5 × 104 CFU mL−1 culture water 
(~2500 bacterial cells per larva). 
Control and bacterial-treated larvae were collected 6 h (for RE22, RI, and S4) and 24 h (for 
probiotics only) post-exposure. These time points were selected in order to determine: a) the early 
immune response of the larvae to the pathogen before onset of mortality at 9 h (Figure 2) the effect of 
probiotic treatment on larval responses immediately prior to RE22 challenge. 
 
Figure 2. Effect of challenge with Vibrio coralliilyticus RE22 on C. virginica larvae. (A) Cumulative 
percent mortality +/− standard error in oyster larvae after 6–20 h of challenge with 5 × 105 CFU mL−1 
of RE22 (n = 6 experiments). Mortality was first observed at 14 h after challenge, and rapidly increased 
thereafter. (B) Actively swimming healthy control larvae. (C) Larvae showing clumping of the cilia 6 
h after challenge. (D) Moribund larva with retracted cilia showing reduced movement at 9 h after 
challenge. (E) Dead larva with empty shells at 14 h after challenge. 
Larvae were aspirated gently from the incubation flasks using a 100 mL serological pipette, 
carefully avoiding to collect the bottom 25 mL (non-swimming and dead larvae). Larvae were filtered 
through a 40 µm sterile filter, washed with 2 mL of AFSW, followed by a wash using 2 mL of 
RNAlater™ (Ambion, Inc., Foster City, CA, United States), aspirated from the 40 µm filter using a 
pipette, and placed in RNase-free microfuge tubes. Larvae were held at 4 °C for 24 h in RNAlater™ 
followed by storage at −20 °C until RNA extraction. 
b) Survival analysis: 
To confirm the effect of treatment on larval survival after RE22 challenge, oyster larvae (~100, 
100–175 µm) were placed in each well of a 6-well plate in 5 mL of AFSW and triplicate wells per 
treatment were incubated at room temperature with 5 × 104 CFU·mL−1 of probionts S4 or RI for 6 or 
24 h prior to bacterial challenge with 5 × 105 CFU mL−1 of RE22. Larval survival was determined 6 h 
(for RE22 and control) and 24 h (for all groups) after challenge as described above. 
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2.6. Effect of Bacterial Treatment on Larval Gene Expression: Hatchery Transcriptomes 
Adult eastern oysters were spawned and larvae were reared in 100 L conical tanks filled with 
filtered and UV treated seawater (20–24 C temperature; 28–30 psu salinity) at the Blount Shellfish 
Hatchery, Roger Williams University, RI following previously described procedures [34]. Briefly, 
larval oysters were distributed into 100 L conical tanks 1 d after fertilization to a density of 8–10 larvae 
per mL of tank water under static conditions with gentle aeration and fed live microalgae daily from 
a microalgae production greenhouse. Treatments (three tanks each) included control and probiont RI 
(104 CFU·mL−1). Probiotic stocks were mixed with algal food and added daily for 15 days at the time 
of feeding. Full tank water changes were performed every 2 days to maintain water quality and 
determine larval growth and survival (Figure 1D). 
a) Transcriptome analysis: 
Larvae for hatchery transcriptomes were collected at three time points: 5, 12, and 16 days post-
fertilization (4, 11, and 15 days of treatment) from probiotic-treated (HT_RI) and control tanks 
(HT_C). Tanks were drained onto a sieve with suitable pore size (75–150 µm depending on the age 
of the larvae) at the time of collection and washed gently with clean seawater. Using a serological 
pipette, larvae were aspirated gently from the sieve and collected in RNase free microfuge tubes with 
RNAlater™ and stored at −80 °C until RNA extraction. 
b) Survival analysis: 
A subsample of larvae was collected from each tank on day 8 post-fertilization to determine the 
effect of exposure to probiont RI in the hatchery on protection against a laboratory challenge with 
pathogen RE22. Levels of protection were determined using the methods described above, with the 
following modifications: a subset of larvae from each tank (3 × HT_C and 3 × HT_RI) were placed in 
triplicate wells of 6-well plates containing 5 mL of AFSW per well, acclimated for a few hours, and 
then directly challenged with V. coralliilyticus RE22 at a dose of 5 × 105 CFU·mL−1. 
2.7. RNA Extraction, cDNA Prep, and Sequencing 
Tri-reagent (Sigma-Aldrich, St. Louis, MO, United States) was used for extracting total RNA 
from all the samples following manufacturer’s instructions. RNA extracts were DNase treated using 
a DNA-free DNA removal kit (Ambion Inc., Foster City, CA, United States) and purity and 
concentration of RNA was assessed using a Nanodrop 8000 spectrophotometer (Thermo Scientific, 
Wilmington, DE, United States). RNA from the two technical replicates in each experiment was 
pooled at equimolar concentration. The quality and quantity of the pools were assessed using Agilent 
2100 Bioanalyzer (Agilent, Santa Clara, CA, United States) and High Sensitivity D1000 ScreenTape® 
(Agilent, Santa Clara, CA, United States). For the laboratory experiments, RNA samples were 
selectively enriched for poly-A containing mRNA and cDNA libraries were prepared using the PrepX 
RNAseq library Prep Kit (Takara Bio USA, Inc, Mountain View, CA, United States). Samples were 
sequenced on Illumina HiSeq platform with 2 × 125 reads at a targeted sequencing coverage of 20–
30M per sample at the Harvard University, FAS Center for Systems Biology, Boston, MA. For the 
hatchery experiments, cDNA libraries were generated using random hexamer priming of total RNA 
and sequenced on Illumina HiSeq platform with 2 × 150 reads and sequencing coverage of 50–70M 
per sample at the McDonnell Genomics Institute, Washington University School of Medicine, MO. 
2.8. Assembly, Annotation, and Differential Expression Analysis 
Raw reads obtained from sequencing were filtered, trimmed, and adapters were removed using 
bbduk program in BBTools suite from Joint Genome Institute and viewed in FASTQC [42]. Processed 
reads were aligned to C. virginica reference genome (version 3.0, GenBank GCA_002022765.4) via 
HISAT2 2.1.0 [43] and assembly was performed using Stringtie [44] using default parameters. To 
compare the depth of sequencing across all samples, preseq package was used [45]. Differential gene 
expression analysis was performed by comparing transcript counts between probiotic (RI and S4; 
replicates K, M, V) or pathogen treatments (RE22; replicates K, M, V) vs the control (replicates K, M, 
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V) using DESeq2 [46]. This design controls for batch effects due to larval environment at the hatchery, 
genetic background of the larvae, and differences in age (all larvae collected were in the veliger 
developmental stage). For hatchery transcriptomes, each of the days (5, 12, and 16 post-fertilization) 
were considered as biological replicates and an overall comparison of treatment vs control was 
conducted. Transcript counts for each replicate were used to determine levels of expression for DEGs 
in each individual time point. This analysis design only allowed for the most conservative estimates 
and only showed differentially expressed genes in all the biological replicates (time points) 
responding to treatment (i.e., RI treatment effect). Transcripts with Benjamini-Hochberg adjusted  
p-value ≤ 0.05 and log fold change of ≥ 2 or ≤ −2 were considered significantly differentially expressed. 
Annotation for differentially expressed genes (DEGs) was performed by mapping to NCBI protein 
non-redundant (NR) database using BLASTx [47] with an e-value cutoff of 1e−3 and hit number 
threshold of 20. Mapping DEGs to GO terms was conducted using BLAST2GO v4.1.9 [48] and 
functional enrichment was done using topGO [49] with default parameters. Significantly enriched 
GO terms were obtained by using Fishers exact test (p ≤ 0.01). 
The raw sequences generated for this study can be found in the NCBI Short Read Archive under 
BioProject no. PRJNA603627 for all laboratory transcriptomes and under BioProject no. PRJNA376014 
for all hatchery transcriptomes. 
3. Results 
3.1. Rapid Mortality in C. virginica Larvae after Challenge with Pathogen V. coralliilyticus RE22 
Oyster larvae exposed to 5 × 105 CFU mL−1 of V. coralliilyticus RE22 showed a rapid decline in 
survival between 9 and 14 h after challenge, reaching about 40% survival at 20 h after challenge 
(Figure 2A). Larvae showed a normal appearance before challenge (Figure 2B). At 6 h after challenge, 
many larvae showed clumping of the cilia by bacteria, leading to reduced motility and feeding 
(Figure 2C). Moribund larvae collected 9 h after challenge showed larvae with cilia drawn in, reduced 
activity, and the presence of bacteria and debris aggregates inside the shells (Figure 2D) and dead 
larvae at 14 h showed no visible sign of live organs or tissue inside their shell, just bacterial aggregates 
and debris (Figure 2E). 
3.2. Pretreatment of Larvae with Probionts RI and S4 for 6 or 24 h before Challenge Conferred Protection 
against Pathogen RE22 
As seen in previous research [33], pretreatment of larvae with probionts B. pumilus RI and P. 
inhibens S4 for 24 h significantly reduced mortality caused by a subsequent challenge with the 
bacterial pathogen V. coralliilyticus RE22 from 39–43% to 72–77% (with RI-pretreated larvae, p < 0.05, 
ANOVA) and 68–70% (with S4-pretreated larvae; p < 0.05, ANOVA), signifying a relative increase in 
percent survival (RPS) in probiotic treated larvae compared to non-treated larvae of around 40% 
(Table 1). 
Table 1. Effect of probiotic pretreatment of oyster larvae for 6 or 24 h in the laboratory or daily for 7 
days in the hatchery on larval survival after experimental challenge with the pathogen V. coralliilyticus 
RE22. 
Treatment 
RPS (average +/− SD) 
6 h 24 h 7 days 
S4 + RE22 37 ± 26 41 ± 2 - 
RI + RE22 30 ± 39 45 ± 5 28 ± 6 
Note: Results are expressed as the relative increase in percent survival (RPS) +/− standard deviation 
(SD; n = 3 experiments) after RE22 challenge of larvae pretreated with probiotics (treatment) as 
compared to challenged larvae (control). S4 + RE22: Larvae pretreated with Phaeobacter inhibens S4 and 
then challenged with V. coralliilyticus RE22. RI + RE22: Larvae pretreated with Bacillus pumilus RI0-695 
and then challenged with V. coralliilyticus RE22. —Not Tested. 
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A shorter duration of S4 or RI pretreatment (6 h) led to an increase in larval survival after 
bacterial challenge from 29–78% with RI-pretreated larvae to 36–72% with S4-pretreated larvae, but 
the levels of protection conferred were highly variable and not significant in one of the three 
experiments performed (see Table 1 for RPS), suggesting variability between larval batches on the 
kinetics of the response to the probiotics. Larvae treated daily with probiotics for 7 days in the 
hatchery, and then exposed to RE22 for 24 h in the laboratory, showed an increase in survival from 
an average of 42% (control tanks) to 63% (RI-treated tanks; see Table 1 for RPS). 
3.3. Transcriptome and Differential Gene Expression Analysis Statistics 
Depth of sequencing for all laboratory transcriptomes ranged from 14–39M paired end reads, 
whereas HT_RI transcriptomes ranged from 50–73M reads (Supplementary Table S1). The alignment 
rate to the C. virginica reference genome using HISAT2 ranged from 83–89% for laboratory 
transcriptomes and from 53–94% for HT_RI and HT_C transcriptomes (Supplementary Table S1). The 
lower percentage of mapped reads to the eastern oyster genome seen in some of the hatchery 
transcriptomes was due to the presence of microbial reads. Sequencing saturation curves for all 
hatchery transcriptomes were comparable between treatments and close to full saturation, indicating 
enough depth of sequencing such that all but the rarest (least abundant) transcripts would be 
represented in the transcriptomes. The percentage of oyster transcripts annotated was 98%. 
The number of differentially expressed genes (DEGs) in each of the pair-wise (control vs. 
treatment) comparisons ranged from 1461 (RE22 at 6 h) to 2892 (S4 at 24 h; Supplementary Table S2). 
Supplementary data tables (S3–S8) include the annotation and log fold change values for DEGs for 
all comparisons. Comparison of the number of shared and unique DEGs across all laboratory 
treatments including pathogen (RE22 6h) and probiotic at both time points (RI and S4; 6 and 24 h; 
Figure 3A) showed more unique transcripts in larvae exposed to probiotic treatments at any time 
point (from 7% of all DEGs for RI6h to 24% for S424h) than in larvae exposed to the pathogen for 6 h 
(5%). Only 5% of the DEGs were shared between all bacterial treatments and time points, with 29% 
shared by the two probiotics (for both time points combined). Larvae treated with probiotics for 24 h 
in the laboratory yielded more DEGs than at 6 h (Figure 3A and Supplementary Table S2), suggesting 
a build-up of the response between 6 and 24 h. A comparison between hatchery transcriptomes 
(HT_RI) at all time points (5, 12, and 16 d post-fertilization; Figure 3B) showed a higher number of 
DEGs at 5 than 12 and 16 d, with 43% of the DEGs being shared between time points. 
 
Figure 3. Comparison of differentially expressed genes in probiotic treatments. (A) Venn Diagram of 
shared and unique differentially expressed genes for larvae exposed to Vibrio coralliilyticus RE22 (6 h), 
probiotic (Bacillus pumilus RI0-695 and Phaeobacter inhibens S4) at 6 h and 24 h in laboratory 
experiments (n = 3). (B) Venn diagram comparing number of differentially expressed genes in 
probiont RI pre-treated larvae at 5, 12, and 16 d post-fertilization (4, 11, and 15 d of RI exposure) as 
compared to the respective untreated control in a hatchery (n = 3 tanks per treatment). 
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3.4. Gene Ontology Enrichment Analysis Showed an Enrichment in Genes Involved in Metabolism in Larvae 
Treated with RE22, but Not in Probiotic Treated Larvae 
A Gene Ontology (GO) term enrichment analysis was performed on all the annotated 
differentially expressed transcripts in response to each treatment (Supplementary Table S9). In RE22 
exposed larvae, there were 18 biological processes significantly enriched (p < 0.05) that mainly 
belonged to metabolism and signaling, but none related to immunity; 17 metabolic functions were 
significantly enriched (p < 0.05) including “receptor activity,” “molecular transducer activity,’ and 
“kinase activity.” Transcripts annotated to the “membrane” category in the GO Cellular component 
class were also significantly enriched. In contrast, S4 treatment showed significant enrichment only 
in processes related to activation of receptors and signaling pathways. No GO terms were 
significantly enriched among DEGs from the comparison between the control and probiotic RI 
treatment in the laboratory, but the hatchery exposure to RI led to enrichment in several categories, 
most of them related to location of molecules/organelles/cells (Supplementary Table S9). The HT_RI 
transcriptomes also showed significant levels of enrichment in more categories, sharing with S4_24 h 
an enrichment in transcripts annotated to the term “cytoskeletal organization.” 
3.5. Contrasting Effects of Treatment with Probionts RI and S4 and Pathogen RE22 on Larval Immunity 
A more detailed analysis of the effect of bacterial exposure on differential gene expression of 
immune-related genes in oyster larvae was performed, illustrated in volcano plots (Figure 4) and heat 
maps (Figure 5). Despite variability in the immune response between batches of larvae [34], some 
significant patterns in immune responses were observed. Overall, larvae treated with RE22 for 6 h 
showed a similar number of upregulated and downregulated immune-related transcripts (Figures 
4A and 5A), while probiotic treatment led to mostly upregulation of immune-related transcripts 
(Figures 4B–F, 5B–D). 
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Figure 4. Effect of bacterial treatments on oyster larval gene expression. Volcano plot representation 
of significantly differentially expressed genes in each treatment versus control C. virginica larvae (p < 
0.05). Dots mark the genes with highly decreased (gold) or increased (blue) expression in (A) Vibrio 
coralliilyticus RE22, (B) probiotic Bacillus pumilus RI06–95 in hatchery, (C, D) probiotic Bacillus pumilus 
RI06–95 in laboratory, and (E, F) probiotic Phaoebacter inhibens S4 exposed larvae compared to control. 
Immune-related differentially expressed genes are highlighted by a larger symbol (∆) in the same 
color scheme. The x-axis shows log2fold-changes in expression and the y-axis the negative log of  
p value of a gene being differentially expressed. Dashed lines indicate thresholds (+/− 2 change in log2 
fold change in gene expression for vertical, 12 −log10P significance for horizontal). 
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Figure 5. Differential expression of immune-related genes between control and pathogen or probiotic 
treated larvae. Heatmap and hierarchical clustering of selected genes based on normalized read 
counts. Each column represents one sample showing the intensity of expression profile per transcript. 
The colors denote the relative standing of the read count data with yellow indicating lower than the 
genes’ average across all samples while blue indicates higher than the average. The expression 
profiles are shown for control condition (C_M, C_K, C_V) for laboratory treatments and (Con5d, 
Con12d, Con16d) for hatchery treatments and (A) pathogen RE22 exposed larvae (RE_M, RE_K, 
RE_V) (B) probiont Bacillus pumilus RI06–95 for hatchery treatment (RI5d, RI12d, RI16d) (C) 6 h 
probiont Bacillus pumilus RI06–95 (RI_M, RI_K, RI_V) and Phaoebacter inhibens S4 exposed larvae 
(S4_M, S4_K, S4_V) for laboratory treatment (D) 24 h probiont Bacillus pumilus RI06–95 (RI_M, RI_K, 
RI_V) and Phaoebacter inhibens S4 exposed larvae (S4_M, S4_K, S4_V) as obtained from DESeq2 
analysis. 
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3.5.1. Pattern Recognition Receptors (PRRs) 
Exposure of larvae to either pathogen or probiotics for 6 h led to an upregulation of transcripts 
coding for fucolectin and one Toll-Like Receptor (TLR), TLR4 (the “shared” PRR response to bacterial 
exposure). Larvae exposed to pathogen RE22 and probiont S4 (both Gram-negative bacteria), but not 
probiont RI (a Gram-positive), also shared the upregulation of tlr13. Exposure to probionts RI and S4 
for 6 h led to a broader response than exposure to RE22, with upregulation of three additional 
transcripts coding for leucine rich receptors LRRC34 (leucine-rich repeats) and LRR4C and a lectin. 
Transcripts for a few additional PRRs were shown to be upregulated in probiotic-treated larvae after 
24 h, including 74ALRR27 (in both RI and S4) and LRR28 (in S4). Probiotic (RI and S4) exposure for 
24 h also led to upregulation of tlr3, a cytosolic receptor that detects non-self nucleic acids. Exposure 
to pathogen led to significant downregulation of gene expression for transcript annotated to three 
PRRs (a scavenger receptor, and two complement C1q-like proteins), while two other PRR transcripts 
were downregulated in response to probiotic exposure (a scavenger receptor for S4 and tlr6 for both 
S4 and RI at 6 h). Downregulation of tlr6 in S4-treated larvae for 6 h was followed by upregulation at 
24 h (Figures 4 and 5). 
3.5.2. Immune Signaling Pathways 
Consistent with the observation that probiotic treatment led to PRR transcript upregulation, 
several transcripts involved in TLR signaling pathways were differentially expressed upon probiotic 
treatment suggesting activation of the NF-kB and MAP kinase (MAPK) pathways. These include 
upregulation of transcripts for activator B-cell lymphoma/leukemia 10-like (bcl10; S46h) and 
downregulation of inhibitor NF-kappa-B inhibitor alpha-like isoform X1 (ikBa; RI)) for the NF-kB 
pathway and upregulation of dual specificity mitogen-activated protein kinase kinase 7-like (map2k7; 
RI, S4), and mitogen-activated protein kinase kinase kinase 7-like (tak1; RI, S4) for the MAPK pathway 
(Figures 4B–F and 5B, C).  
Interestingly, in larvae treated with RE22, and despite upregulation of tlr4 and tlr13, transcripts 
related to the TLR signaling pathway, including myeloid differentiation primary response protein 
MyD88-like (myd88), TNF receptor-associated factor 4-like (traf4), and tak1 showed downregulation 
(Figures 4A, 5A). In addition, the genes coding for several members of the NF-kB pathway were 
downregulated upon RE22 challenge, including those for NF-kappa-B-activating protein-like (nkap) 
and ikBa. A transcript for toll-interacting protein-like (tollip, an inhibitory adaptor protein that 
interacts with several TLR signaling pathway components) was downregulated. In contrast to the 
downregulation of key molecules of the canonical NF-kB pathway, the gene coding for an essential 
component of the MAPK signal transduction pathway, mkk7 (dual specificity mitogen-activated 
protein kinase kinase 7-like), was upregulated. 
3.5.3. Immune Effectors 
Probiotic treatment in the laboratory led to modulation of gene expression for three types of 
major immune effectors: serine protease inhibitors (cvspi2, spi), mucins, both secreted gel-forming 
mucins (muc2, muc5a, muc5b, muc19) and cell surface mucins (muc3b, muc4, muc12), and macrophage-
expressed gene 1 protein-like (mpeg1/perforin-2) (Figures 4B–F and 5B, C). Larvae exposed to RI in the 
hatchery also showed a complex pattern of mucin gene expression, with transcripts coding for several 
mucins showing upregulation (muc17, hkr1), and others downregulation (muc2, muc4, muc5a). 
Hatchery larvae also showed upregulation of a transcript for the antimicrobial histone H2B. 
Conversely, and consistent with the downregulation of transcripts involved in immune signaling 
pathways observed in RE22 treated larvae, the only immune effector differentially expressed in 
response to RE22 as compared to control were two types of transcripts related to mucin (muc2, 
muc12). 
  
Vaccines 2020, 8, 588 13 of 23 
 
3.5.4. Other Immune Molecules 
Several transcripts related to antiviral pathways including stimulator of interferon genes 
protein-like (sting; all bacterial treatments) and some members of the JAK-STAT pathway (jak2 
(tyrosine-protein kinase JAK2-like); S4 and RE22) were upregulated in response to bacterial 
exposures (Figures 4 and 5). Differentially expressed transcripts corresponding to ubiquitin carboxyl-
terminal hydrolase 25-like isoform X3 (usp25) were only seen in response to RE22. Moreover, several 
transcripts related to programmed cell death pathways were shown to be differentially expressed in 
larvae exposed to pathogen or probionts RI and S4 as compared to control larvae. These included 
upregulation of transcripts corresponding to autophagy related gene atg9a (autophagy-related 
protein 9A-like) and modulation (a combination of upregulation and downregulation, depending on 
the treatment and time) of several transcripts associated with the apoptosis pathway coding for death 
domain-containing protein CRADD-like (death domain-containing protein CRADD-like), initiator 
and executioner caspases, GTPase of the immune-associated protein 7 (GIMAP7, only in response to 
RI exposure in the hatchery), and several types of baculoviral inhibitor of apoptosis (IAP) repeat-
containing proteins (Inhibitor of apoptosis protein) (Figures 4 and 5). In particular, expression of 
caspase1, a key component of the inflammasome, was highly and consistently upregulated in all three 
bacterial treatments (Figure 4). Moreover, prostaglandin G/H synthase 2-like (PTGS2), important in 
inflammation, was also highly upregulated in all probiotic treatments except S4_24h. 
3.5.5. Gene Expression Patterns Show Signs of Metabolic Demand and Stress in RE22 Exposed 
Larvae 
Multiple transcripts annotated as cox3 (cyt oxidase c subunit III (mitochondrion)), hspa12a (heat 
shock proteins), and hspa12b, which are involved in metabolism and stress, were seen as differentially 
expressed in all bacterial treatments (Supplementary Tables S3–S8). However, RE22 exposed larvae 
showed consistent upregulation of these genes, especially in cox3 (Figure 4A, 5A), whereas probiotic 
treatments showed a complex response, with both up- and downregulation of multiple transcripts 
depending on probiotic type or time of exposure (listed in Supplementary Tables S3–S8). In addition, 
transcripts coding for antioxidant enzymes, generally expressed to protect the host from a successful 
respiratory burst response to bacterial exposure, were not detected among significant DEGs in RE22 
challenged larvae. In contrast, transcripts annotated as antioxidant enzymes were downregulated in 
probiotic treated larvae but not RE22 challenge, including transcripts coding for superoxide 
dismutase (SOD) and glutathione peroxidase 7-like (GPX7) that were downregulated in S4 (24h), and 
transcripts annotated as glutathione S-transferase (GST) downregulated in RI (6h and HT_RI) and S4 
(24 h). 
4. Discussion 
The pathogen V. coralliilyticus RE22 and other pathogenic vibrios have been identified as a major 
threat to bivalve larvae worldwide [17], including Crassostrea virginica, a bivalve species of major 
commercial and ecological value in the Atlantic Coast of North America. A better understanding of 
the array of mechanisms used by different vibrio species to cause disease in a variety of shellfish 
species is needed in order to develop targeted tools for disease management, such as probiotics and 
immunomodulator molecules. This research focused on characterizing the immune response of C. 
virginica to (a) bacterial pathogen V. coralliilyticus RE22 in order to understand mechanisms of 
pathogenesis in larval vibriosis and (b) bacterial probiotics B. pumilus RI06–95 and P. inhibens S4 in 
order to understand the role of immunomodulation in protection against RE22. Differential 
expression and functional enrichment analyses of oyster larvae 6 h after challenge with the bacterial 
pathogen V. coralliilyticus RE22 showed that larval oysters were able to recognize the pathogen, as 
indicated by upregulation of pattern recognition receptor genes tlr4 and tlr13, but unable to mount 
an efficient immune response, evidenced by the downregulation of transcripts for several key genes 
in immune signaling pathways and the overall lack of expression in immune effector genes in 
response to RE22. This is in contrast with the responses of larval eastern oysters to probiotic treatment 
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observed in our study (summarized in Figure 6), as well as results from previous studies in oysters 
and other bivalves showing a diversity of immune effectors, such as antimicrobial peptides (e.g., 
defensins), lysozymes, pore forming molecules like perforin, and serine protease inhibitors, produced 
in response to bacterial challenge (reviewed in [50]). 
 
Figure 6. Summary of major impacts of challenge with Vibrio coralliilyticus RE22 and probiotic 
treatments with Bacillus pumilus RI06–95 and Phaoebacter inhibens S4 on Crassostrea virginica larval 
immune responses. (A) Exposure of larvae to probionts S4 and RI induced the expression of a large 
variety of immune genes, suggesting a strong immune response comprising pathogen recognition 
through a variety of PRRs with upregulation of several TLRs, lectins, and LRRs, activation of immune 
signaling pathways (e.g., TLR, NF-kB, MAPK, JAK-STAT and cGAS-STING), and upregulation of an 
arsenal of immune effectors (mucins, serine protease inhibitors, and perforin-2). DEGs also suggest 
modulation of cell death pathways and inflammation. (B) In contrast, in response to challenge with 
RE22, only a few immune receptors were upregulated, and several signaling molecules in the NF-kB 
pathway were downregulated (e.g., myd88 and tak1), suggesting inactive immune signaling pathways 
resulting in lack of immune effectors. Upregulation of stress-related genes cox3 and hsp12a suggest 
increased metabolic demand. Response showed absence of transcripts coding for antioxidant 
enzymes to combat oxidative stress. Purple represents gene upregulation, gold downregulation, and 
grey no change in expression. 
4.1. Pathogenesis of RE22 Vibriosis in Eastern Oyster Larvae: Role of Immunosuppression and Metabolic 
Stress 
This research confirms the ability of RE22 to cause morbidity and mortality in eastern oyster 
larvae [14,16,51]. The dose of the pathogen RE22 used in these challenge experiments was similar to 
vibrio concentrations measured in temperate coastal environments during certain seasons and 
environmental conditions [9], and concentrations used in other challenge experiments performed for 
evaluation of transcriptomic responses in bivalves [20,52,53]. 
Our research suggests that targeted suppression of some immune pathways may be involved in 
the pathogenesis of vibriosis in larval oysters. In general, successful immune responses to gram 
negative bacteria, including vibrios, in oysters and other bivalves involve pathogen recognition by 
TLRs such as TLR13 and TLR4 (responding to 23S ribosomal RNA and LPS, respectively) (reviewed 
in [50]). Upon recognition of lipopolysaccharide (LPS) by TLR4, the receptor initiates the activation 
of the NF-kB and AP-1 (MAPK-dependent) pathways through recruitment of the adaptor molecule 
MyD88, currently the only known adaptor protein in bivalves, into the TIR domains of TLRs. 
Activation of TLR and interleukin-17 (IL-17) pathways ultimately leads to expression of immune 
effectors such as antimicrobial peptides and lysozyme, radical oxygen species (ROS) activation 
through respiratory burst, and expression of antioxidant genes. The NF-kB and MAPK signaling 
pathways also regulate apoptosis and inflammation (reviewed in [50,54]). 
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In eastern oyster larvae exposed to RE22, despite upregulation of tlr4 and tlr13, genes for key 
immune signaling molecules that are usually upregulated in response to LPS in bivalves, such as 
myd88, tak1, and nkap [50,55] were instead downregulated, probably leading to the lack of expression 
in immune effectors regulated by the NF-kB signaling pathways seen in this study. Although 
downregulation of ikb⍺, an inhibitor of NF-kB, could potentially lead to transcription of immune 
effectors, changes in expression of these molecules are difficult to interpret, due to the complex 
feedback loop regulating NF-kB [55–57]. Another unexpected finding in this regard was the unique 
downregulation in vibrio but not probiotic-treated larvae of tollip, a negative immune regulator 
involved in the inhibition of pro-inflammatory responses to LPS [58]. Downregulation of tollip has 
also been reported 6 h after challenge of Yesso scallops, Patinopecten yessoensis, with V. anguillarum 
[59]. The function of Tollip in invertebrates is not well understood, but in vertebrates, it has been 
associated with a variety of signaling pathways, and its response to LPS is highly dependent on dose 
and context [60]. If TOLLIP has a similar function in oysters than in mammals, the downregulation 
of tollip, combined with the high levels of expression of caspase1, would be consistent with an 
inflammatory-like response in RE22 treated larvae, a response that has also been seen by histological 
examination [51]. In this sense, challenge of larvae with RE22 also led to an upregulation of gene 
expression for several molecules involved in the MAPK signaling pathway, including mkk7 and jak2, 
suggesting that this pathway may not be directly targeted by RE22. Moreover, in addition to 
upregulation of the gene for TLR13 (an intracellular PRR involved in stimulation of expression of 
immune effectors through MyD88–NF-KB pathways; [61]), eastern oyster larvae exposed to RE22 
showed upregulation of transcripts for STING, a key regulator for sensing intracellular single- or 
double-stranded nucleic acids that acts via the cGAS-STING pathway complex with TAK1 to trigger 
expression of interferon-related genes [62,63]. These results suggest that RE22 could be a facultative 
intracellular pathogen of larval oysters, as shown for other vibrio species affecting bivalves, such as 
V. tasmaniensis LGP32 [20,64]. Further functional research would be needed to identify the specific 
targets of RE22 immunosuppression in larval oysters, and its putative intracellular nature. 
Evidence of host immunosuppression in response to pathogenic vibrios is in accordance with 
previous research in invertebrate hosts. Disturbance of host immune responses has been reported in 
adult Pacific oysters at early time points post challenge with virulent Vibrio sp., V. splendidus LGP32-
GFP and V. estuarianus 02/041 [52], as well as V. crassostreae J2–9 [20]. Transcriptomic studies 
investigating the responses of coral Pocillopora damicornis to V. coralliilyticus YB1, which causes disease 
and bleaching in corals, also reported immunosuppression of the host [65,66]. Hemocytes of 
Mediterranean mussels, Mytilus galloprovincialis, are also unable to mount an efficient immune 
response towards V. coralliilyticus challenge, as shown by a lack of production of antimicrobial 
proteins and signs of lysosomal stress [18]. Moreover, while injection of sterile seawater into mussel 
tissues leads to expression of antimicrobial peptides (indicating that injection serves as a danger 
signal), mussels injected with V. splendidus do not show this upregulation in antimicrobial production 
[67]. These results, however, contrast with findings in scallop Argopecten purpuratus gills or adult 
giant clam Tridacna crocea hemocytes exposed to vibrio challenge, which showed upregulation of 
these immune pathways [68,69], suggesting that the immunosuppressive effects of vibrios on bivalve 
hosts depend on host and pathogen species and host developmental stage (adult versus planktonic 
larvae). 
The inability of larval eastern oysters to mount a rapid and efficient immune response probably 
contributes to the rapid pathogen proliferation observed in larval tissues, accompanied by increased 
metabolic demand and signs of stress leading to heavy mortality seen within hours after challenge. 
Upregulation of cox3, hspa12a, and hspa12b is a key indicator of high metabolic demand and oxidative 
stress [70], and the lack of expression of genes coding for antioxidant enzymes suggests that larvae 
are unable to effectively handle the oxidative stress and high metabolic demand due to the inability 
to rapidly clear RE22 infection. This is consistent with the well-documented effect of bacterial 
infection on the transcriptomes of susceptible bivalve hosts [53,67,71–73]. 
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4.2. Protection against RE22 Challenge in Probiotic-Treated Eastern Oyster Larvae: Role of 
Immunomodulation 
This research also confirms the ability of probionts B. pumilus RI06–95 and P. inhibens S4 to 
protect eastern oyster larvae against challenge with RE22 when provided to the larvae at least 24 h 
before challenge [33,34]. In contrast to the oyster larvae response of RE22 challenge, exposure of 
larvae to probionts S4 and RI induced the expression of a variety of immune genes, suggesting a 
strong immune response comprising pathogen recognition through a variety of PRRs, activation of 
immune signaling pathways, and production of an arsenal of immune effectors. This probiotic 
mechanism of larval immunostimulation is consistent with our previous observations that probiotics 
are cleared from the larvae within 12–24 h after treatment [33]. These immune effectors activated in 
larvae upon probiotic exposure may also serve to provide protection against RE22 challenge, by 
leading to the production of immune effectors before RE22 has a chance to lead to 
immunosuppression in the host (Figure 5B–D). 
Consistent with expectations based on the study of immunity against bacterial pathogens in 
bivalves and other species, as described in the section above, differential expression analysis in 
response to both probiotics suggests activation of various immune signaling pathways like TLR, NF-
kB, and MAPK, leading to upregulation of transcripts for effectors involved in immune killing, cell 
proliferation, apoptosis and cell death, and the inflammatory response. Several probiotics are known 
to modulate (either activate or suppress) signaling pathways that benefit the host and protect them 
from pathogens [29,74–77]. Usually, probiotics show a very strain specific response in other host 
species [76,78]. In this case, however, despite the difference in Gram character between S4 and RI, 
many immune transcripts, especially effectors, were expressed in response to both probiotics. Our 
findings showing that tlr3 (RI24h, S424h), tlr4 (RI6h), tlr6 (S424h), tlr8 (RI24h), and tlr13 (RI24h, S46h) 
were upregulated in response to probiotics are consistent with the important role of the TLR pathway 
in bivalve immune responses, and indicate the potential of probiotics to provide protection against a 
broad spectrum of pathogens. Such PRR activation by these probiotics due to shared cell envelope 
components such as lipopolysaccharides, peptidoglycans, and bacterial DNA with pathogens is well 
known [79]. 
Transcriptome analysis also suggests that activation of these pathways leads to increased 
transcription of a variety of immune effectors by probiotics that may have activity against vibrios and 
other pathogens. Perforin-2/Mpeg1, highly upregulated in larvae treated with either probiotic in the 
laboratory exposures, is an important ancient innate immune system effector that functions by 
forming pores in intracellular and extracellular pathogenic bacteria [80]. LPS exposure significantly 
upregulated a perforin-2 in oysters [81] and other invertebrates [82,83]. In addition to other functions, 
such as osmoregulation and responses to environmental stress, mucus is an important line of defense 
that plays multiple roles in the host-microbe interactions, including buffering pathogen secreted 
proteases and preventing invasion of pathogens through a vast array of immune recognition and 
effector proteins beneficial to the host that become embedded in the mucus layer [84–87]. All probiotic 
treatments showed highly upregulated serine protease inhibitors Cvspi2 and spi, which might serve 
to neutralize serine proteases from RE22. Serine protease inhibitors like cvSI-1 have been shown to 
inhibit proliferation of the parasite Perkinsus marinus [88,89] and are upregulated in resistant eastern 
oysters in response to challenge with the pathogen A. crassostreae [72]. The presence of these immune 
effectors in larval tissues as a result of probiont RI and S4 pretreatment immediately prior to RE22 
challenge may contribute to expedited clearing of the pathogen, alone or in combination with the 
ability of S4 to directly inhibit pathogen colonization and growth through antibiotic production, 
biofilm formation, and interference with quorum sensing in the pathogen [38,39]. 
Unique aspects of the HT_RI transcriptomes, which reflects continuous exposure in the hatchery 
to the probiotic versus a single exposure in the laboratory, was the upregulation of transcripts coding 
for histone H2B-like, GIMAP7, and several septins, and the enrichment of GO terms related to 
transport and localization of molecules/organelles/cells. Histones show antimicrobial action against 
Gram negative bacteria and in C. gigas has been demonstrated to surround and engulf vibrios  
[90–92]. GIMAP7 is a member of GTPase of the immune-associated proteins family that acts an 
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apoptosis regulator [93]. Transcripts coding for various apoptosis inhibitors, as well as several 
caspases, were also differentially expressed in response to S4 and RI laboratory treatments, but these 
complex patterns are difficult to interpret due to the complexity of cell death pathways and the large 
expansion of genes involved in apoptosis seen in oysters [94]. In other organisms, autophagy and 
septins together restrict cytosolic bacterial replication [95]. Cytoskeletal rearrangements can help in 
bacterial sensing, compartmentalization, and phagocytosis of pathogens [96,97] as well as autophagy 
and apoptosis for host protection [98]. The role of these processes in immune responses in bivalves 
requires further research. 
5. Conclusions 
This study indicates that immunomodulation may contribute to the mechanisms of action of 
probionts RI and S4 against RE22 challenge, serving to overcome the immunosuppressive effects of 
RE22 on larvae. Additionally, differential gene expression analysis indicative of a high metabolic 
demand and oxidative stress are consistent with the rapid mortality observed during RE22 infection 
in oyster larvae. Further functional studies are required to tease out details of the mechanisms used 
by RE22 to manipulate the immune system of oyster larvae through targeting of immune signaling 
pathways. This study represents the first deep analysis of larval transcriptomes of eastern oysters in 
response to both bacterial pathogen and probionts, providing many candidate genes and specific 
pathways that should be targeted in the future for further characterization of mechanisms of Vibrio 
pathogenesis and probiotic immunomodulation. Based on this research, hatchery management 
solutions targeted to enhance the production of host immune effectors, such as immunostimulation 
by use of probiotics, should be evaluated as a cost-effective, natural, and environmentally-friendly 
solution for disease management. 
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